Evidence map›Paper›PMID 31940393›Full record

ArticlePloS one2020

Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation.

Kai Niu, Chunjie Guo, Shiyong Teng, Dandan Zhou, Shuyuan Yu, Wanzhong Yin, Ping Wang, Wei Zhu, Maoli Duan

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Pepsin enhances glycolysis to promote malignant transformation of vocal fold leukoplakia epithelial cells with dysplasia.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Article
  9. Article
  10. Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Review
  11. Article
  12. Pepsin and Laryngeal and Hypopharyngeal Carcinomas.Clinical and experimental otorhinolaryngology · 2021
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Kai NiuDepartment of Otolaryngology Head and Neck Surgery, the First Hospital of Jilin University, Changchun, PR China.ORCID 0000-0003-2040-6887
Chunjie GuoDepartment of Radiology, the First Hospital of Jilin University, Changchun, PR China.
Shiyong TengDepartment of Anesthesiology, the First Hospital of Jilin University, Changchun, PR China.
Dandan ZhouDepartment of Radiology, the First Hospital of Jilin University, Changchun, PR China.
Shuyuan YuDepartment of Otolaryngology Head and Neck Surgery, the First Hospital of Jilin University, Changchun, PR China.
Wanzhong YinDepartment of Otolaryngology Head and Neck Surgery, the First Hospital of Jilin University, Changchun, PR China.
Ping WangDepartment of Otolaryngology Head and Neck Surgery, the First Hospital of Jilin University, Changchun, PR China.
Wei ZhuDepartment of Otolaryngology Head and Neck Surgery, the First Hospital of Jilin University, Changchun, PR China.
Maoli DuanDepartment of Clinical Science, Intervention and Technology, Department of Otolaryngology Head and Neck Surgery, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
Jilin University · CNKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pepsin plays an important role in laryngopharyngeal reflux (LPR), a risk factor for the development of hypopharyngeal squamous cell carcinomas (HPSCC). However, the role of pepsin in HPSCC is not clear. We show by immunohistochemistry that pepsin positivity occurs in a significant proportion of human primary HPSCC specimens, and in many cases matched adjacent uninvolved epithelia are negative for pepsin. Pepsin positivity is associated with nodal involvement, suggesting that pepsin may have a role in metastasis. Treatment of FaDu cancer cells with pepsin increased cell proliferation, possibly by inducing G1/S transition. We also observed significant changes in expression of genes involved in NF-kappaB, TRAIL and Notch signaling. Our data suggest that pepsin plays an important role in HPSCC and that targeting pepsin could have potential therapeutic benefits.

Indexed as

G1 PhaseGene Expression Regulation, NeoplasticSignal TransductionS PhaseAgedCarcinoma, Squamous CellCell Line, TumorFemaleHumansLaryngeal NeoplasmsMaleMiddle AgedNeoplasm MetastasisNeoplasm ProteinsPepsin APharyngeal NeoplasmsNeoplasm ProteinsPepsin A

Identifiers

PMID31940393
PMCPMC6961942
OpenAlexW3000613737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.